4.7 Article

Causal Graph Among Serum Lipids and Glycemic Traits: A Mendelian Randomization Study

Journal

DIABETES
Volume 71, Issue 8, Pages 1818-1826

Publisher

AMER DIABETES ASSOC
DOI: 10.2337/db21-0734

Keywords

-

Funding

  1. National Natural Science Foundation of China [82021005, 81973148, 82003561]

Ask authors/readers for more resources

This study systematically investigated the causal relationships among HDL cholesterol, LDL cholesterol, triglycerides, fasting insulin, and glycated hemoglobin A(1c). The results suggest that insulin resistance is a strong causal factor of high triglycerides and low HDL cholesterol, highlighting the importance of early control of insulin resistance to prevent type 2 diabetes, dyslipidemia, and cardiovascular complications.
We systematically investigated the bidirectional causality among HDL cholesterol (HDL-C), LDL cholesterol (LDL-C), triglycerides (TGs), fasting insulin (FI), and glycated hemoglobin A(1c) (HbA(1c)) based on genome-wide association summary statistics of Europeans (n = 1,320,016 for lipids, 151,013 for FI, and 344,182 for HbA(1c)). We applied multivariable Mendelian randomization (MR) to account for the correlation among different traits and constructed a causal graph with 13 significant causal effects after adjusting for multiple testing (P < 0.0025). Remarkably, we found that the effects of lipids on glycemic traits were through FI from TGs (beta = 0.06 [95% CI 0.03, 0.08] in units of 1 SD for each trait) and HDL-C (beta = -0.02 [-0.03, -0.01]). On the other hand, FI had a strong negative effect on HDL-C (beta = -0.15 [-0.21, -0.09]) and positive effects on TGs (beta = 0.22 [0.14, 0.31]) and HbA(1c) (beta = 0.15 [0.12, 0.19]), while HbA(1c) could raise LDL-C (beta = 0.06 [0.03, 0.08]) and TGs (beta = 0.08 [0.06, 0.10]). These estimates derived from inverse-variance weighting were robust when using different MR methods. Our results suggest that elevated FI was a strong causal factor of high TGs and low HDL-C, which in turn would further increase FI. Therefore, early control of insulin resistance is critical to reduce the risk of type 2 diabetes, dyslipidemia, and cardiovascular complications.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available